LLY

1,099.05

+0.23%↑

JNJ

228.76

+0.25%↑

ABBV

226.26

+4.41%↑

UNH

404.45

+1.04%↑

NVS

147.42

+0.41%↑

LLY

1,099.05

+0.23%↑

JNJ

228.76

+0.25%↑

ABBV

226.26

+4.41%↑

UNH

404.45

+1.04%↑

NVS

147.42

+0.41%↑

LLY

1,099.05

+0.23%↑

JNJ

228.76

+0.25%↑

ABBV

226.26

+4.41%↑

UNH

404.45

+1.04%↑

NVS

147.42

+0.41%↑

LLY

1,099.05

+0.23%↑

JNJ

228.76

+0.25%↑

ABBV

226.26

+4.41%↑

UNH

404.45

+1.04%↑

NVS

147.42

+0.41%↑

LLY

1,099.05

+0.23%↑

JNJ

228.76

+0.25%↑

ABBV

226.26

+4.41%↑

UNH

404.45

+1.04%↑

NVS

147.42

+0.41%↑

Search

Laboratory Corp of America Holdings

Fermé

SecteurSoins de santé

255.92 -1.23

Résumé

Variation du prix de l'action

24h

Actuel

Min

254.31

Max

256.1

Chiffres clés

By Trading Economics

Revenu

113M

278M

Ventes

22M

3.5B

P/E

Moyenne du Secteur

23.563

49.712

BPA

4.25

Rendement du dividende

1.09

Marge bénéficiaire

7.858

Employés

71,000

EBITDA

130M

548M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+21.12% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

1.09%

2.36%

Prochains Résultats

23 juil. 2026

Date du Prochain Dividende

10 sept. 2026

Date du Prochain Détachement de Dividende

27 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

108M

22B

Ouverture précédente

257.15

Clôture précédente

255.92

Sentiment de l'Actualité

By Acuity

50%

50%

118 / 342 Classement par Healthcare

Laboratory Corp of America Holdings Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

À Propos Laboratory Corp of America Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.
help-icon Live chat